©The Author(s) 2025.
World J Gastrointest Oncol. Dec 15, 2025; 17(12): 113387
Published online Dec 15, 2025. doi: 10.4251/wjgo.v17.i12.113387
Published online Dec 15, 2025. doi: 10.4251/wjgo.v17.i12.113387
Table 1 General information of the 24 patients, n (%)
| Characteristics | Values |
| Male/female | 16 (66.66)/8 (33.33) |
| Age, mean ± SD (years) | 63.25 ± 10.06 |
| Tumor site | |
| Head and neck of the pancreas | 6 (25.00) |
| Body and tail of the pancreas | 18 (75.00) |
| AJCC tumor stage | |
| II | 16 (66.66) |
| III | 8 (33.33) |
| Preoperative comorbidities | |
| Pain | 20 (83.33) |
| Obstructive jaundice | 4 (16.67) |
| Gastrointestinal obstruction | 2 (8.33) |
| Tumor invasion of blood vessels | |
| Superior mesenteric artery | 1 (4.16) |
| Celiac trunk/common hepatic artery | 4 (16.67) |
| Portal vein/superior mesenteric vein | 6 (25.00) |
| Both arterial and venous invasion | 13 (54.17) |
- Citation: Kang LM, He XL, Lang L, Wang AY, Wang X, Liu YH, Zhao YH, Xu L, Yu FK, Zhang FW. Safety and efficacy of cryoablation in treating locally advanced pancreatic cancer. World J Gastrointest Oncol 2025; 17(12): 113387
- URL: https://www.wjgnet.com/1948-5204/full/v17/i12/113387.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i12.113387